Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in GhanaArticle Published on 2018-06-012023-06-18 Journal: The Journal of Infection [Category] B형 간염, [키워드] booster HBV hypertension kidney tenofovir. [DOI] 10.1016/j.jinf.2018.03.001 PMC 바로가기
Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?Review Published on 2018-02-012023-06-16 Journal: Human vaccines & immunotherapeutics [Category] B형 간염, [키워드] Anti-HBs booster Breakthrough infection Hepatitis B vaccine. [DOI] 10.1080/21645515.2017.1397243 PMC 바로가기 [Article Type] Review
Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, EgyptArticle Published on 2017-06-012023-06-16 Journal: J Egypt Public Health Assoc [Category] B형 간염, [키워드] booster Hepatitis B virus Hepatitis B virus surface antigen seroprotection. vaccination [DOI] 10.21608/epx.2018.8945 PMC 바로가기
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness AnalysisArticle Published on 2017-02-012023-06-02 Journal: Journal of General Internal Medicine [Category] 두창, 수두, 홍역, [키워드] booster cost-effectiveness herpes zoster. [DOI] 10.1007/s11606-016-3844-6 PMC 바로가기
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness AnalysisArticle Published on 2017-02-012023-06-02 Journal: Journal of General Internal Medicine [Category] 두창, 홍역, [키워드] booster cost-effectiveness herpes zoster. [DOI] 10.1007/s11606-016-3844-6 PMC 바로가기
Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in GermanyArticle Published on 2016-03-032023-06-18 Journal: Human vaccines & immunotherapeutics [Category] B형 간염, [키워드] Adolescent Anti-HBs booster hepatitis B immune memory persistence Infant vaccination. [DOI] 10.1080/21645515.2015.1105414 PMC 바로가기
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialHIV-1에 감염된 건강한 성인에서 후보 결핵 백신 MVA85A의 안전성, 면역원성 및 효능: 무작위, 위약 대조, 2상 시험Articles Published on 2015-03-012022-09-06 Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, [키워드] 1:1 95% CI absence active tuberculosis adverse event Antigen antigen 85A antigen 85A-specific T-cell response antiretroviral Antiretroviral therapy assigned assist baseline baseline CD4 block blocks booster Cape CD4 count CD4 counts Cell clinical defined detect detectable Developing disease double-blind effective Efficacy eligible Eligible participants enrolled enrolment European Evidence evidence of expressing finding first vaccination foundation funding gold greater Group allocation had no healthy HIV-1 HIV-1 infection immunogenic immunogenicity include increased risk Infection injection intradermal injections investigators isoniazid isoniazid prophylaxis Laboratory latent tuberculosis latent tuberculosis infection M tuberculosis Measures Melinda Gate Melinda Gates modified vaccinia virus MVA85A Mycobacterium tuberculosis nine no evidence of Nurses occurred outcome participant partnership peaked per-protocol analysis per-protocol population Phase 2 phase 2 trial Placebo placebo group placebo-controlled positive Potential Prophylaxis protocol QuantiFERON QuantiFERON-TB Gold In-Tube randomisation randomised Randomly receive receiving Registered reported Safe Safety safety analysis second vaccination secondary Secondary outcomes sequence Serious Adverse Event Serious Adverse Events significant increase South Africa stratified subset T-cell Response the placebo group therapy town Treatment Trial Tuberculosis tuberculosis disease tuberculosis vaccine undetectable vaccination Vaccine vaccine efficacy vaccine-induced immune response Viral Viral load Wellcome Trust were assessed [DOI] 10.1016/S2213-2600(15)00037-5 PMC 바로가기 [Article Type] Articles
Booster and higher antigen doses of inactivated influenza vaccine in HIV-infected patientsReview Published on 2013-12-012023-06-24 Journal: The Annals of Pharmacotherapy [Category] 신종인플루엔자, [키워드] booster High dose HIV immunize increased antigen Influenza vaccine. [DOI] 10.1177/1060028013507901 PMC 바로가기 [Article Type] Review
Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendationsReview Published on 2013-11-012023-05-31 Journal: International Journal of Infectious Diseases [Category] A형 간염, [키워드] booster dosage hepatitis A virus inactivated vaccine. [DOI] 10.1016/j.ijid.2013.04.012 PMC 바로가기 [Article Type] Review
Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c miceArticle Published on 2013-01-012022-10-06 Journal: Journal of Virology [Category] 진단, [키워드] administration Antigen approach approach BALB/c BALB/c mice booster contraindication different effectively controlled Efficacy ENCODE expressing H5N1 highly pathogenic immune responses immunization inactivated Infection Influenza Influenza virus intramuscular intramuscular vaccination intranasal lung mucosal IgA response Neutralizing New pandemic parainfluenza virus Prevent PROTECT Protective recombinant required robust serum antibody response shown single vaccine tested the vaccine threat vaccination Vaccine Vaccine development Vaccines virion Virology virus virus replication viruses while [DOI] 10.1128/JVI.02330-12 PMC 바로가기 [Article Type] Article